ArticleFrontiers in cellular and infection microbiology2026
A conjugated polymer antimicrobial agent triggers metabolic cascade-mediated killing of carbapenem-resistant
Article in Frontiers in cellular and infection microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum issued
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Carbapenem-resistant Methods: We developed a light-tunable conjugated polymer, P3, designed to penetrate CRKP biofilms and achieve spatiotemporally controlled activation. Its efficacy was evaluated against established CRKP biofilms in both dark and visible light conditions, assessing biofilm biomass elimination and bacterial viability. Results: P3 leveraged its intrinsic optical properties and ROS production to eliminate 50% of the CRKP biofilm in darkness. Upon visible light irradiation, its efficacy was dramatically enhanced via a triggered compensatory self-destruction (CSD) mechanism. This self-amplifying reaction catastrophically disrupted bacterial membrane integrity and oxidative balance, resulting in the internal destruction of over 80% of the biofilm and bacterial death. This action combines physical matrix breakdown with ROS-mediated biomolecular damage, leading to near-complete biofilm eradication. Discussion: Our study demonstrates that P3 functions as a "metabolic time bomb," providing a targeted, antibiotic-free strategy against structured bacterial communities. These findings highlight the significant potential of this light-controlled platform for treating resistant biofilm-associated infections.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.